US Patent Issued to CytomX Therapeutics on Dec. 16 for "Methods of qualitatively and/or quantitatively analyzing properties of activatable antibodies and uses thereof" (California Inventors)

ALEXANDRIA, Va., Dec. 16 -- United States Patent no. 12,498,367, issued on Dec. 16, was assigned to CytomX Therapeutics Inc..

"Methods of qualitatively and/or quantitatively analyzing properties of activatable antibodies and uses thereof" was invented by Olga Vasiljeva (Cupertino, Calif.), Stephen James Moore (Danville, Calif.), Bruce Howng (San Francisco), Susan K. Lyman (South San Francisco, Calif.) and Luc Roland Desnoyers (San Francisco).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides methods and kits for qualitatively and/or quantitatively analyzing activation and other properties of activatable antibody therapeutic in biological samples, including tissues and/or biofluid samples. T...